Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Myeloma 2017 meeting is a high-level discussion forum for research leaders in the field of myeloma, in order to further our understanding of recent advances in myeloma, and to encourage interactive discussion. This conference will take place in Edinburgh from 18th October to 20th October.

iwMyeloma 2017

18–20 October 2017 | Edinburgh

iwMyeloma 2017

18–20 October 2017 | Edinburgh

The Myeloma 2017 meeting is a high-level discussion forum for research leaders in the field of myeloma, in order to further our understanding of recent advances in myeloma, and to encourage interactive discussion. This conference will take place in Edinburgh from 18th October to 20th October.

Genetic elements driving IMiD resistance in multiple myeloma 0:54
Genetic elements driving IMiD resistance in multiple myeloma
Benjamin Barwick • 18 Oct 2017
Targeting DNA methylation as a therapeutic target in multiple myeloma 0:47
Targeting DNA methylation as a therapeutic target in multiple myeloma
Benjamin Barwick • 18 Oct 2017
Analyzing genetic and epigenetic markers of high-risk multiple myeloma 2:16
Analyzing genetic and epigenetic markers of high-risk multiple myeloma
Benjamin Barwick • 18 Oct 2017
Exciting new developments in multiple myeloma 9:41
Exciting new developments in multiple myeloma
Daniel Auclair et al. • 18 Oct 2017
Utilizing combination therapies for multiple myeloma 1:11
Utilizing combination therapies for multiple myeloma
David Avigan • 18 Oct 2017
Why use model systems for multiple myeloma research? 11:15
Why use model systems for multiple myeloma research?
Enrique Ocio et al. • 18 Oct 2017
The future of immunotherapy in multiple myeloma 11:24
The future of immunotherapy in multiple myeloma
Hearn Jay Cho et al. • 18 Oct 2017
Novel therapeutics in multiple myeloma 13:23
Novel therapeutics in multiple myeloma
Christoph Driessen et al. • 18 Oct 2017
The use of CAR T-cells in multiple myeloma 9:48
The use of CAR T-cells in multiple myeloma
Adam Cohen et al. • 18 Oct 2017
Multiple myeloma: genomic evolution 9:32
Multiple myeloma: genomic evolution
Jonathan Keats et al. • 18 Oct 2017
The exciting field of imaging in multiple myeloma 6:48
The exciting field of imaging in multiple myeloma
Jens Hillengass et al. • 18 Oct 2017
Liquid biopsies for multiple myeloma: the attractions and limits 3:33
Liquid biopsies for multiple myeloma: the attractions and limits
Jens Lohr • 18 Oct 2017
Liquid biospy approaches for detecting MM and their optimization 1:40
Liquid biospy approaches for detecting MM and their optimization
Suzanne Trudel • 18 Oct 2017
Detecting common mutations in MM patients through liquid biopsy 4:00
Detecting common mutations in MM patients through liquid biopsy
Suzanne Trudel • 18 Oct 2017
Myeloma 2017: an epigenetic research boom 2:35
Myeloma 2017: an epigenetic research boom
Felipe P. Cardoso • 18 Oct 2017
Where no man has gone before: the technologies being used to explore MM epigenetic factors 1:34
Where no man has gone before: the technologies being used to explore MM epigenetic factors
Felipe P. Cardoso • 18 Oct 2017

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals